High incidence of large deletions in the PMS2 gene in Spanish Lynch syndrome families

Lynch syndrome (LS) is caused by germline mutations in one of the four mismatch repair (MMR) genes. Defects in this pathway lead to microsatellite instability (MSI) in DNA tumors, which constitutes the molecular hallmark of this disease. Selection of patients for genetic testing in LS is usually based on fulfillment of diagnostic clinical criteria (i.e. Amsterdam criteria or the revised Bethesda guidelines). However, following these criteria PMS2 mutations have probably been underestimated as their penetrances appear to be lower than those of the other MMR genes. The use of universal MMR study‐based strategies, using MSI testing and immunohistochemical (IHC) staining, is being one proposed alternative. Besides, germline mutation detection in PMS2 is complicated by the presence of highly homologous pseudogenes. Nevertheless, specific amplification of PMS2 by long‐range polymerase chain reaction (PCR) and the improvement of the analysis of large deletions/duplications by multiplex ligation‐dependent probe amplification (MLPA) overcome this difficulty. By using both approaches, we analyzed 19 PMS2‐suspected carriers who have been selected by clinical or universal strategies and found five large deletions and one frameshift mutation in PMS2 in six patients (31%). Owing to the high incidence of large deletions found in our cohort, we recommend MLPA analysis as the first‐line method for searching germline mutations in PMS2.

[1]  J. Hopper,et al.  Recurrent and founder mutations in the PMS2 gene , 2013, Clinical genetics.

[2]  J. Swensen,et al.  The frequency of previously undetectable deletions involving 3′ Exons of the PMS2 gene , 2013, Genes, chromosomes & cancer.

[3]  J. Potter,et al.  Identification of Lynch syndrome among patients with colorectal cancer. , 2012, JAMA.

[4]  M. Baudis,et al.  Improved Multiplex Ligation-Dependent Probe Amplification Analysis Identifies a Deleterious PMS2 Allele Generated by Recombination with Crossover Between PMS2 and PMS2CL , 2012, Genes, chromosomes & cancer.

[5]  J. Swensen,et al.  Avoidance of pseudogene interference in the detection of 3′ deletions in PMS2 , 2011, Human mutation.

[6]  Á. Carracedo,et al.  Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer , 2011, Gut.

[7]  Pinar Bayrak-Toydemir,et al.  Clinical analysis of PMS2: mutation detection and avoidance of pseudogenes , 2010, Human mutation.

[8]  H T Lynch,et al.  Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications , 2009, Clinical genetics.

[9]  J. Potter,et al.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. , 2008, Gastroenterology.

[10]  A. de la Chapelle,et al.  A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome , 2008, Journal of Medical Genetics.

[11]  A. de la Chapelle,et al.  Long‐range PCR facilitates the identification of PMS2‐specific mutations , 2006, Human mutation.

[12]  D. Bonthron,et al.  Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome. , 2004, American journal of human genetics.

[13]  K. Kinzler,et al.  Genomic organization of the human PMS2 gene family. , 1995, Genomics.

[14]  P. Peltomäki Lynch Syndrome Genes , 2004, Familial Cancer.

[15]  C. Boland,et al.  Evolution of the Nomenclature for the Hereditary Colorectal Cancer Syndromes , 2004, Familial Cancer.